Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

Recruiting now · Not applicable

Conditions studied: Thyroid Cancer

In brief

The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).

Key facts

Study ID

NCT06222606

Run by

Aarhus University Hospital

People needed

160

Starts

2024-01-01

Expected to finish

2027-01-01

Last updated by the study team

2025-10-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age>18 years and able to give informed consent.
• Suspicion or diagnosis of thyroid cancer.
• Planned total thyroidectomy or completion thyroidectomy.
• Normocalcemia prior to surgery.

You may not qualify if…

• Planned simultaneous parathyroid surgery.
• Treatment with active vitamin D analogues.
• eGFR < 30.

Where it is running

• Aarhus University Hospital — Aarhus, Denmark, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.